by The Welthi Bureau | 08th Feb, 2019
A Memorandum of Understanding (MoU) was signed between the L V Prasad Eye Institute (LVPEI), India and the Antonio Champalimaud Foundation, Lisbon, Portugal for advancing the treatment of eye cancer. The collaboration will aim to seek innovative and pioneering Eye Cancer treatment solutions, and also allow for genetic, molecular and cellular analysis. Champalimaud Centre for the Unknown's (CCU) Cancer Program is the most advanced in the world.
The formal MoU was signed by Dr. Gullapalli N. Rao, Founder-Chair, LVPEI and Dr. Leonor Beleza, President, Antonio Champalimaud Foundation. Also present were Mr. Joao Botelho, Vice President, and Prof. Antonio Parreira, Clinical Director, Champalimaud Foundation, and Dr. S. Shivaji, Director of Research, LVPEI.
Specialized Eye Cancer treatment is a highly advanced subspecialty clinical eye care service provided at the LVPEI. The Institute's "Operation Eyesight Institute for Eye Cancer" is led by a dedicated and experienced team that provides state of the art care for Eye Cancer of all types.
The goal of this program is to understand and prevent cancer. This is particularly critical for India, as Eye Cancer (Retinoblastoma) is most common in children. This collaboration will hopefully bring new insights and therapeutic approaches to the problem of Eye Cancer.
Love Thyself - A Valentine's Day Message
7 Step Treatment For Spotless Skin
POWERFUL PROPERTIES OF THE HUMBLE BRINJAL
Neuberg Diagnostics & OptraSCAN® announce the ...
Keyhole Surgery: A revolution in malignant and ...
DELAY AGEING BY FASTING
World Stroke Day 29th Oct 2018
Hyderabad Doctors successfully perform Asia's ...
SuVitas Launches Bangalore’s First Dedicated ...
Itermittent Fasting: The How s and Why's
Our responsibility to our emotions
Eyes show you the world